PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Candesartan cilexetil
Presentation Product Chemical substance Chapter Items dispensed
Candesartan 8mg tablets
0205052C0AAACAC
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 456,944
Candesartan 4mg tablets
0205052C0AAABAB
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 377,416
Candesartan 16mg tablets
0205052C0AAADAD
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 375,557
Candesartan 32mg tablets
0205052C0AAAHAH
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 246,906
Candesartan 2mg tablets
0205052C0AAAAAA
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 171,355
Candesartan 4mg/5ml oral liquid
0205052C0AAAIAI
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 6
Candesartan 8mg/5ml oral liquid
0205052C0AAAJAJ
Candesartan cilexetil Candesartan cilexetil Cardiovascular System 1
Candesartan 16mg/5ml oral solution
0205052C0AAAKAK
Candesartan cilexetil Candesartan cilexetil Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.